You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.
This fast track antibody is not yet fully characterized. It is subject to these terms and conditions

Overview

  • Product nameAnti-LD78 beta antibodySee all LD78 beta primary antibodies ...
  • Description
    Goat polyclonal to LD78 beta

    This product is a fast track antibody. It has been affinity purified and shows high titre values against the immunizing peptide by ELISA. Read the terms of use »

  • SpecificityThis product is expected to recognize the products of 2 different genes which are almost identical.
  • Species reactivity

    Predicted to work with: Human, Chimpanzee
  • Immunogen

    Synthetic peptide: EWVQKYVSDLELSA, corresponding to C terminal amino acids 80-93 of Human LD78 beta

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris saline. pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesPurified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • Clonality Polyclonal
  • IsotypeIgG
  • Research Areas

Applications

  • Application notesThis antibody gave a positive result in ELISA against the immunizing peptide. Antibody detection limit dilution 1:32,000.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionChemotactic for lymphocytes and monocytes. Is a ligand for CCR1, CCR3 and CCR5. Is an inhibitor of HIV-1-infection. The processed form LD78-beta(3-70) shows a 20-fold to 30-fold higher chemotactic activity and is a very potent inhibitor of HIV-1-infection. LD78-beta(3-70) is also a ligand for CCR1, CCR3 and CCR5.
    • Sequence similaritiesBelongs to the intercrine beta (chemokine CC) family.
    • Post-translational
      modifications
      The N-terminal processed forms LD78-beta(3-70) and LD78-beta(5-70) are produced by proteolytic cleavage after secretion from peripheral blood monocytes. The cleavage to yield LD78-beta(3-70) is probably achieved by DPP4.
    • Cellular localizationSecreted.
    • Target information above from: UniProt accession P16619 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt
    • Database links
    • Alternative names
        464.2 antibodyC C motif chemokine 3 like 1 antibodyCCL3L1 antibody
        CCL3L3 antibodyChemokine (C C motif) ligand 3 like 1 antibodyChemokine (C C motif) ligand 3 like 3 antibodyChemokine (C C motif) ligand 3 like, centromeric antibodychemokine (CC motif) ligand 3 like 1 antibodyCL3L1_HUMAN antibodyD17S1718 antibodyG0/G1 switch regulatory protein 19-2 antibodyG0S19-2 antibodyLD78 antibodyLD78 beta(1-70) antibodyLD78-beta(1-70) antibodyLD78-beta(5-70) antibodyLD78BETA antibodyMGC104178 antibodyMGC12815 antibodyMGC182017 antibodyMIP1AP antibodyPAT 464.2 antibodySCYA3L antibodySCYA3L1 antibodySmall inducible cytokine A3 like 1 precursor antibodySmall-inducible cytokine A3-like 1 antibodyTonsillar lymphocyte LD78 beta antibodyTonsillar lymphocyte LD78 beta protein antibody
      see all

    References for Anti-LD78 beta antibody (ab36129)

    ab36129 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab36129.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"